A novel cellular defect in diabetes: membrane repair failure

Diabetes. 2011 Nov;60(11):3034-43. doi: 10.2337/db11-0851. Epub 2011 Sep 22.

Abstract

Objective: Skeletal muscle myopathy is a common diabetes complication. One possible cause of myopathy is myocyte failure to repair contraction-generated plasma membrane injuries. Here, we test the hypothesis that diabetes induces a repair defect in skeletal muscle myocytes.

Research design and methods: Myocytes in intact muscle from type 1 (INS2(Akita+/-)) and type 2 (db/db) diabetic mice were injured with a laser and dye uptake imaged confocally to test repair efficiency. Membrane repair defects were also assessed in diabetic mice after downhill running, which induces myocyte plasma membrane disruption injuries in vivo. A cell culture model was used to investigate the role of advanced glycation end products (AGEs) and the receptor for AGE (RAGE) in development of this repair defect.

Results: Diabetic myocytes displayed significantly more dye influx after laser injury than controls, indicating a repair deficiency. Downhill running also resulted in a higher level of repair failure in diabetic mice. This repair defect was mimicked in cultured cells by prolonged exposure to high glucose. Inhibition of the formation of AGE eliminated this glucose-induced repair defect. However, a repair defect could be induced, in the absence of high glucose, by enhancing AGE binding to RAGE, or simply by increasing cell exposure to AGE.

Conclusions: Because one consequence of repair failure is rapid cell death (via necrosis), our demonstration that repair fails in diabetes suggests a new mechanism by which myopathy develops in diabetes.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism*
  • Cell Membrane / radiation effects
  • Cell Membrane / ultrastructure
  • Cells, Cultured
  • Diabetes Mellitus, Type 1 / complications*
  • Diabetes Mellitus, Type 2 / complications*
  • Fluorescent Dyes / metabolism
  • Fluorescent Dyes / toxicity
  • Glycation End Products, Advanced / adverse effects
  • Glycation End Products, Advanced / antagonists & inhibitors
  • Glycation End Products, Advanced / metabolism
  • Hyperglycemia / metabolism
  • Lasers / adverse effects
  • Mice
  • Mice, Inbred C57BL
  • Mice, Mutant Strains
  • Motor Activity
  • Muscle Fibers, Skeletal / drug effects
  • Muscle Fibers, Skeletal / metabolism*
  • Muscle Fibers, Skeletal / radiation effects
  • Muscle Fibers, Skeletal / ultrastructure
  • Muscular Diseases / metabolism*
  • Muscular Diseases / pathology
  • Myoblasts, Skeletal / metabolism
  • Necrosis
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic / metabolism

Substances

  • Fluorescent Dyes
  • Glycation End Products, Advanced
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic